Cargando…
Cation-Chloride Cotransporters KCC2 and NKCC1 as Therapeutic Targets in Neurological and Neuropsychiatric Disorders
Neurological diseases including Alzheimer’s, Huntington’s disease, Parkinson’s disease, Down syndrome and epilepsy, and neuropsychiatric disorders such as schizophrenia, are conditions that affect not only individuals but societies on a global scale. Current therapies offer a means for small symptom...
Autores principales: | Lam, Patricia, Newland, Julia, Faull, Richard L. M., Kwakowsky, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9920462/ https://www.ncbi.nlm.nih.gov/pubmed/36771011 http://dx.doi.org/10.3390/molecules28031344 |
Ejemplares similares
-
NKCC1 and NKCC2: The pathogenetic role of cation-chloride cotransporters in hypertension
por: Orlov, Sergei N., et al.
Publicado: (2015) -
Cryo-EM structures of the full-length human KCC2 and KCC3 cation-chloride cotransporters
por: Chi, Ximin, et al.
Publicado: (2020) -
The structural basis of function and regulation of neuronal cotransporters NKCC1 and KCC2
por: Zhang, Sensen, et al.
Publicado: (2021) -
Structure of the human cation–chloride cotransport KCC1 in an outward-open state
por: Zhao, Yongxiang, et al.
Publicado: (2022) -
Structural basis for inhibition of the Cation-chloride cotransporter NKCC1 by the diuretic drug bumetanide
por: Zhao, Yongxiang, et al.
Publicado: (2022)